Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Insmed Inc

INSM
Current price
71.4 USD -1.22 USD (-1.68%)
Last closed 73.02 USD
ISIN US4576693075
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 12 544 976 896 USD
Yield for 12 month +195.65 %
1Y
3Y
5Y
10Y
15Y
INSM
21.11.2021 - 28.11.2021

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey. Address: 700 US Highway 202/206, Bridgewater, NJ, United States, 08807

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

88.53 USD

P/E ratio

Dividend Yield

Current Year

+305 208 000 USD

Last Year

+245 358 000 USD

Current Quarter

+90 340 000 USD

Last Quarter

+75 500 000 USD

Current Year

+239 635 000 USD

Last Year

+190 232 000 USD

Current Quarter

+68 113 000 USD

Last Quarter

+56 780 000 USD

Key Figures INSM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -634 945 984 USD
Operating Margin TTM -205.01 %
PE Ratio
Return On Assets TTM -24.77 %
PEG Ratio
Return On Equity TTM -1453.41 %
Wall Street Target Price 88.53 USD
Revenue TTM 328 604 992 USD
Book Value 0.23 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 17 %
Dividend Yield
Gross Profit TTM 190 232 000 USD
Earnings per share -5.41 USD
Diluted Eps TTM -5.41 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -244.27 %

Dividend Analytics INSM

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History INSM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 03.03.2011
Dividend Date

Stock Valuation INSM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 37.815
Price Sales TTM 38.1765
Enterprise Value EBITDA -6.0454
Price Book MRQ 320.8724

Financials INSM

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators INSM

For 52 weeks

21.92 USD 80.53 USD
50 Day MA 74.28 USD
Shares Short Prior Month 12 234 912
200 Day MA 45.93 USD
Short Ratio 5.65
Shares Short 12 218 173
Short Percent 7.21 %